Lucia Zabalza
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Early real-world effectiveness of mirikizumab in a difficult-to-treat ulcerative colitis cohort.
Journal: Gastroenterologia y hepatologia
Published: June 01, 2026
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.
Journal: Alimentary pharmacology & therapeutics
Published: March 28, 2026
Overall survival, clinical significance and biochemical composition of 'white bile' in patients with impaired biliary drainage: a systematic review.
Journal: Journal of physiology and biochemistry
Published: November 12, 2025
Longitudinal assessment of pancreatic exocrine dysfunction in type 1 diabetes.
Journal: World journal of diabetes
Published: August 22, 2025
Early advanced therapies and real-world outcomes in Crohn's disease: A population-based comparison of two incident cohorts in Navarra.
Journal: Gastroenterologia y hepatologia
Published: June 13, 2025
Atezolizumab induced new-onset type 1 diabetes mellitus.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: January 13, 2023
Infliximab-induced hypoglycemia, a rare but relevant side effect.
Journal: Revista espanola de enfermedades digestivas
Published: February 04, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026